Prediction of 1-year all-cause mortality in thoracic aortic dissection (TBAD) patients undergoing thoracic endovascular aortic repair (TEVAR) Circulatory System
Conditions
Interventions
This retrospective cohort study evaluates thoracic aortic dissection (TBAD) patients who underwent thoracic endovascular aortic repair (TEVAR) between January 2011 and June 2023. A total of 57 preoper
Sponsors
Changhai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with TBAD at Changhai Hospital (Shanghai, China) from January 2011 to June 2023.
Exclusion criteria
Exclusion criteria: 1. Cases of traumatic aortic injury and iatrogenic aortic dissection 2. The presence of Turner syndrome, Marfan syndrome, Ehlers-Danlos syndrome, bicuspid aortic valve, giant cell arteritis, ankylosing spondylitis, Behçet's disease, or Takayasu arteritis 3. A history of previous aortic surgical interventions 4. A documented history of malignancy 5. A lack of baseline data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year all-cause mortality measured using data collected from a retrospective cohort thoracic aortic dissection (TBAD) patients who underwent thoracic endovascular aortic repair (TEVAR) between January 2011 and June 2023 at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
China
Contacts
Public ContactShuangshuang Li
Outcome results
None listed